Aethlon Medical
AEMD
12 hedge funds and large institutions have $1.26M invested in Aethlon Medical in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 12 → 12 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
25% less capital invested
Capital invested by funds: $1.69M → $1.26M (-$427K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$14K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$14K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$256K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$66K |
| 3 |
VF
Virtu Financial
New York
|
-$28K |
AEMD Hedge Fund Activity: Q3 2018 in Review
12 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q3 2018, worth a combined $1.26M — down 25% from $1.69M a quarter earlier.
Fund positioning in AEMD was balanced in Q3 2018: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $14K. The largest seller was Millennium Management, exiting entirely with an estimated $256K sold.
- 12 institutional investors held Aethlon Medical (AEMD) as of Q3 2018, unchanged from Q2 2018.
- Funds reported $1.26M of Aethlon Medical stock for Q3 2018, down 25% quarter-over-quarter.
- 2 funds opened new Aethlon Medical positions in Q3 2018 and 2 closed out, a net change of 0 holders.
- The largest Aethlon Medical buyer in Q3 2018 was Citadel Advisors, an estimated $14K added.
- The largest Aethlon Medical seller in Q3 2018 was Millennium Management, an estimated $256K sold.
Based on aggregated 13F filings for Q3 2018.